Complete radiological response after sorafenib treatment for advanced hepato-cellular carcinoma

Nour, Elleuch; Rym, Ennaifer; Hayfa, Romdhane; Meryam, Cheikh; Rania, Hefaiedh; Wassila, Bougassas; Houda, Ben Nejma; Najet, Bel Hadj

Nour, Elleuch; Rym, Ennaifer; Hayfa, Romdhane; Meryam, Cheikh; Rania, Hefaiedh; Wassila, Bougassas; Houda, Ben Nejma; Najet, Bel Hadj.

Tunisie Medicale [La]. 2015; 93 (6): 350-352

en Inglés | IMEMR | ID: emr-177346

ABSTRACT

ABSTRACT

Introduction:

Sorafenib, an oral multikinase inhibitor, has recently been shown to improve overall survival in patients with advanced hepatocellular carcinoma [HCC] but only a handful of reports of complete remission on sorafenib have been issued

Buscar en Google

Imprimir

XML

Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Tunisie Med. Año: 2015

Similares

MEDLINE

LILACS

LIS

Buscar en Google

Imprimir

XML

Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Tunisie Med. Año: 2015